Steven Patierno

Core Faculty

Steven Patierno, PhD

Contact

steven.patierno@duke.edu

Focus Areas
Degree

PhD, University of Texas Medical School at Houston

Dr. Patierno's current translational research interests are focused on the genomics molecular biology of cancer disparities, cancer biology, molecular pharmacology and targeted experimental therapeutics to control prostate, breast and lung tumor aggressiveness. He is an internationally recognized expert in cancer control, cancer causation and molecular carcinogenesis, which includes a broad spectrum of laboratory and population level research.   He is also actively engaged in cancer health disparities and healthcare delivery research focused on patient navigation, survivorship, community-based interventions, mHealth, implementation sciences, cancer care economics, and policy.

From Scholars@Duke

Scholars@Duke Profile
Patierno BM, Foo W-C, Allen T, Somarelli JA, Ware KE, Gupta S, et al. Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestry. In: Prostate Cancer Prostatic Dis. 2021.

George DJ, Halabi S, Heath EI, Sartor AO, Sonpavde GP, Das D, et al. A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer. Cancer. 2021 Aug 15;127(16):2954–65.

Al Abo M, Hyslop T, Qin X, Owzar K, George DJ, Patierno SR, et al. Differential alternative RNA splicing and transcription events between tumors from African American and White patients in The Cancer Genome Atlas. Genomics. 2021 May;113(3):1234–46.